Delivery Order SPE2DB24D2100-SPE2DB25FBFSA
- Not listed
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Department of Defense's Medical Supply Chain awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 6, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with Defense Logistics Agency Troop Support...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Talzenna 0.5 mg softgel capsules in 30-count packages. The award has a ceiling value of $11,135.25 and is a firm fixed-price contract. The period of performance runs through June 10, 2025. Amerisourcebergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.08 firm fixed-price delivery order is for the supply of Talzenna 0.5 mg capsules. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product, with a ceiling value of $12,235.91 and a period of performance through May 2, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, with a ceiling value of $11,135.25 and a period of performance through July 29, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD7YN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,848.16 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Talzenna 0.5 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.5 MG SOFTGEL 30S, a pharmaceutical product, with a ceiling value of $11,135.25 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFSADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, fulfills this order as part of its comprehensive role as a pharmaceutical prime vendor for military and healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic areas. Talzenna, a prescription oncology medication, supports the Defense Health Agency's pharmaceutical supply chain and broader military healthcare operations. As a non-set-aside award, this delivery order reflects the contractor's demonstrated capability to compete successfully for federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/6/25 |